Microbiome of Donor Iron Deficient Study
NCT02990988 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2022-09-19
Summary
The goal of this pilot study is to test whether the microbiome is affected by intravenous iron repletion.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Eldad Hod, MD · Associate Professor of Pathology and Cell Biology, Dept of Pathology&Cell Biology
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2022-06-03
- Completion
- 2022-06-03
Countries
- United States
Study Locations
More Related Trials
-
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
NCT00304408 ·Status: COMPLETED
-
Longitudinal Study of the Human Intestinal Microbiome
NCT00832286 ·Status: COMPLETED ·Phase: PHASE1
-
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
NCT02896244 ·Status: COMPLETED
-
Fecal Microbiota Transplantation for C Diff Infection
NCT01905709 ·Status: RECRUITING ·Phase: NA
-
Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
NCT02269150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
NCT00377078 ·Status: UNKNOWN ·Phase: NA
-
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
NCT03988855 ·Status: UNKNOWN ·Phase: PHASE2
-
Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission
NCT03494101 ·Status: UNKNOWN
-
Fecal Calprotectin: Cheap Marker for Diagnosing Acute Infectious Diarrhea
NCT00429325 ·Status: COMPLETED
-
Clostridium Difficile Infection (CDI) in Hematologic Patients.
NCT03964844 ·Status: UNKNOWN
-
Protocol for Admission Toxigenic C. Difficile Surveillance
NCT04014608 ·Status: COMPLETED
-
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
NCT02255305 ·Status: TERMINATED ·Phase: PHASE2
-
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
NCT02127398 ·Status: RECRUITING ·Phase: PHASE2
-
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders
NCT01099111 ·Status: COMPLETED
-
CMTS0929 for Clostridioides Difficile Infection
NCT06836427 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
NCT05714566 ·Status: RECRUITING
-
Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes
NCT00446355 ·Status: COMPLETED
-
Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)
NCT01716533 ·Status: COMPLETED ·Phase: NA
-
Metabolome and Microbiomic in Fecal Samples
NCT00938028 ·Status: COMPLETED
-
Studies of the Human Microbiome in Clinical Center Patients
NCT01933620 ·Status: ENROLLING_BY_INVITATION
-
Fidaxomicin to Prevent Clostridium Difficile Colonization
NCT01552668 ·Status: WITHDRAWN ·Phase: PHASE4
-
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
NCT02326636 ·Status: COMPLETED
-
Protective Immunity to Human Cholera in Bangladesh
NCT00349999 ·Status: COMPLETED
-
Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection
NCT02395848 ·Status: TERMINATED ·Phase: PHASE3
-
Personalized Needs in Clostridium Difficile Infections
NCT02573571 ·Status: COMPLETED